Rosacea Clinical Trial - Effect of CD07805/47 Gel in Rosacea Flushing

Status Completed

Clinical Trial Summary

Phase IIa study to assess the efficacy and safety of CD07805/47 0.5% gel in the treatment of the flush of rosacea.

Clinical Trial Description

This is a single-centre, randomized, Investigator masked, placebo controlled study comprising the following 2 parts.

During the part I of study, 36 subjects will receive on site the following treatments during one week (the order of each session being randomized) under intra-individual design:

- placebo on both sides of the face,

- one side of the face treated with CD07805/47 0.5% gel, the other side treated with placebo (the allocation of treatment on each half-face will be determined according to a randomization list),

- CD07805/47 0.5% gel on both sides of the face;

During the part II of study, the same subjects will receive during 4 weeks the following treatments on the whole face (once a day 7 days a week, at home) in parallel groups:

- 18 subjects will receive the CD07805/47 0.5% gel the first 2 weeks and then the placebo and;

- 18 subjects will receive the placebo the first 2 weeks and then the CD07805/47 0.5% gel, according to randomization. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Rosacea

Clinical Trial Details

NCT number	NCT02300129
Study type	Interventional
Source	Galderma R&D
Contact
Status	Completed
Phase	Phase 2
Start date	April 2014
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05597462` - Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks	Phase 1
Completed	`NCT02601963` - Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT02249065` - Mirvaso in Use Study	Phase 4
Completed	`NCT02292797` - Assessment of the Rosacea Prevalence in the General Population	N/A
Completed	`NCT01659853` - Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea	Phase 3
Completed	`NCT01426269` - Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo	Phase 4
Completed	`NCT00991198` - The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage	Phase 2
Terminated	`NCT04336163` - Skin Imaging to Inform Laser Treatments	N/A
Recruiting	`NCT04108897` - Analysis of the Microbiome in Rosacea	Early Phase 1
Completed	`NCT03872050` - Deep Phenotyping of Rosacea and Migraine
Active, not recruiting	`NCT06033352` - Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea	Phase 2
Completed	`NCT03263273` - Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT04508660` - CGB-400 for the Reduction of Facial Redness	Phase 1
Completed	`NCT04508205` - CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes	Phase 1
Completed	`NCT05094700` - A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants	N/A
Active, not recruiting	`NCT03211585` - EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA	N/A
Completed	`NCT02637232` - Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Completed	`NCT02576860` - Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle	Phase 3
Completed	`NCT02576847` - Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel	Phase 3
Completed	`NCT02583009` - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea	Phase 2